 |
|
May 7, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- Actinium: Enrollment of First Patient in the
Iomab-ACT Commercial CAR-T Trial at the
University of Texas Southwestern Medical
Center More
- BioAegis Therapeutics: Site Activation and
Patient Recruitment Underway in 13 Countries
in Phase 2b Clinical Trial of Gelsolin, an
Immune Regulator, for the Treatment of Acute
Respiratory Distress Syndrome (ARDS) More
- Daiichi Sankyo and AstraZeneca: ENHERTU
Followed by THP Before Surgery Showed
Statistically Significant and Clinically
Meaningful Improvement in Pathologic Complete
Response in Patients With High-Risk HER2
Positive Early-Stage Breast Cancer in
DESTINY-Breast11 Phase 3 Trial More
More*
- GRIN Therapeutics: Receives Positive Opinion
for EU Orphan Designation for Radiprodil for
Treatment of GRIN-Related Neurodevelopmental
Disorder
More
- Tharimmune: Positive Clinical Data
Highlighting TH104 Metabolic Profile and
Advances Program for Prophylaxis Against
Ultrapotent Opioid Exposure Following FDA
Feedback More
- Tiziana Life Sciences: Comprehensive
Positive Results From Study of Nasal Foralumab
in Patients With Multiple Sclerosis
More
- Y-mAbs: Update to National Comprehensive
Cancer Network (NCCN) Clinical Practice
Guidelines in Oncology for Neuroblastoma to
Include Naxitamab-gqgk (DANYELZA) More
|
|
- Amarin: First Quarter 2025 Financial Results
More
- BMS Makes $40M Commitment to US, but
Manufacturing Plans Unclear More*
More
More
More
- Cognition Therapeutics: Financial Results
for the First Quarter 2025 and Business Update
More
- ICYMI: Correction From Source:
Firefly Neuroscience Achieves Multi-Fold
Database, IP Portfolio, and Commercial
Footprint Expansion Through Acquisition of
Evoke Neuroscience, Inc. More
- Inductive Bio: Raises $25M Series A to
Transform Small Molecule Drug Discovery With
Industry-Wide AI Platform More
- More on Bristol Myers Cutting Over 500 Jobs
as Part of Restructuring More*
- Nuvectis Pharma: First Quarter 2025
Financial Results and Business Highlights More
- PTC Therapeutics: Corporate Update and First
Quarter 2025 Financial Results
More More*
- The DeGregorio Family Foundation: $1 Million
Awarded to Improve Immunotherapy in
Gastroesophageal Cancer More
|
|
|
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
highlighted on our
website. |
|
|
|
|
|
|
NOTE: EVENTS AND JOBS ARE FROM
ALL BIG4BIO REGIONS
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- OPPORTUNITY: Chief Executive Officer More
- OPPORTUNITY: Chief Product Officer More
- OPPORTUNITY: Vice President, Digital Health
Business Development More
- OPPORTUNITY: Chief Business Officer More
- OPPORTUNITY: Vice President, Finance More
- OPPORTUNITY: Director, Compliance &
Quality Systems
More
- OPPORTUNITY: West Coast Business Development
Director
More
- OPPORTUNITY: Chief Financial Officer More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
